UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis”

Journal of hepatology, 2024-07, Vol.81 (1), p.e43-e44

2024

Volltextzugriff (PDF)

Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

Journal of hepatology, 2024-07, Vol.81 (1), p.e41-e42

2024

Volltextzugriff (PDF)

Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease

European journal of pharmaceutical sciences, 2017-11, Vol.109, p.269-279

2017

Volltextzugriff (PDF)

Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Journal of hepatology, 2010-07, Vol.53 (1), p.191-198

2010

Volltextzugriff (PDF)

A case of dual-targeted therapy for pediatric refractory inflammatory bowel disease

Zhonghua er ke za zhi, 2024-06, Vol.62 (6), p.577

2024

Volltextzugriff (PDF)

Drug therapy in the heart transplant recipient. Part II: Immunosuppressive drugs

Circulation (New York, N.Y.), 2004-12, Vol.110 (25), p.3858-3865

2004

Volltextzugriff (PDF)

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention

Clinical and experimental dermatology, 2019-06, Vol.44 (4), p.363-369

2019

Volltextzugriff (PDF)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

World journal of gastroenterology : WJG, 2017-01, Vol.23 (3), p.414-425

2017

Volltextzugriff (PDF)

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Inflammatory bowel diseases, 2017-06, Vol.23 (6), p.946-955

2017

Volltextzugriff (PDF)

Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy

Pharmacotherapy, 2017-03, Vol.37 (3), p.305-318

2017

Volltextzugriff (PDF)

The Effect of Immunosuppression on Airway Integrity

Transplantation, 2017-12, Vol.101 (12), p.2855-2861

2017

Volltextzugriff (PDF)

Safety issues in the management of autoimmune hepatitis

Expert opinion on drug safety, 2008-05, Vol.7 (3), p.319-333

Czaja, Albert J

2008

Volltextzugriff (PDF)

Time to Relapse in Children with Crohn’s Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids

Digestive diseases and sciences, 2016-07, Vol.61 (7), p.2041-2050

2016

Volltextzugriff (PDF)

Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option

Therapeutic drug monitoring, 2017-02, Vol.39 (1), p.1-4

2017

Volltextzugriff (PDF)

Optimizing thiopurine therapy in inflammatory bowel disease

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1428-1435

2011

Volltextzugriff (PDF)

Azathioprine does not influence patch test reactivity in Parthenium dermatitis

Contact dermatitis, 2016-01, Vol.74 (1), p.64-65

2016

Volltextzugriff (PDF)

Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review

Journal of digestive diseases, 2016-10, Vol.17 (10), p.652-659

2016

Volltextzugriff (PDF)

Quantitative patterns of azathioprine adherence after renal transplantation

Transplantation, 2009-03, Vol.87 (5), p.711-718

2009

Volltextzugriff (PDF)

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1257-1258

2016

Volltextzugriff (PDF)

Current and novel immunosuppressive therapy for autoimmune hepatitis

Hepatology (Baltimore, Md.), 2002, Vol.35 (1), p.7-13

2002

Volltextzugriff (PDF)

Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use

Journal of clinical pharmacy and therapeutics, 2014-04, Vol.39 (2), p.107-111

2014

Volltextzugriff (PDF)

Role of pharmacogenetics of immunosuppressive drugs in organ transplantation

Therapeutic drug monitoring, 2008-04, Vol.30 (2), p.143-150

2008

Volltextzugriff (PDF)

Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment

Seminars in respiratory and critical care medicine, 2011-06, Vol.32 (3), p.298-309

2011

Volltextzugriff (PDF)

Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment

Journal of Crohn's and colitis, 2014-06, Vol.8 (6), p.558-559

2014

Volltextzugriff (PDF)

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease

Journal of gastroenterology and hepatology, 2008-09, Vol.23 (9), p.1373-1377

2008

Volltextzugriff (PDF)

1 – 25 von 373

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaFemale

ThemaImmunosuppressive Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(298)
Mit Volltextzugriff
(214)

Publikationsform

Artikel
(372)
magazinearticle
(1)

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis”

Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

Development and in vivo evaluation of chitosan beads for the colonic delivery of azathioprine for treatment of inflammatory bowel disease

Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

A case of dual-targeted therapy for pediatric refractory inflammatory bowel disease

Drug therapy in the heart transplant recipient. Part II: Immunosuppressive drugs

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy

The Effect of Immunosuppression on Airway Integrity

Safety issues in the management of autoimmune hepatitis

Time to Relapse in Children with Crohn’s Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids

Azathioprine Therapy in a Pediatric TPMT-Deficient Patient-Still an Option

Optimizing thiopurine therapy in inflammatory bowel disease

Azathioprine does not influence patch test reactivity in Parthenium dermatitis

Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review

Quantitative patterns of azathioprine adherence after renal transplantation

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

Current and novel immunosuppressive therapy for autoimmune hepatitis

Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use

Role of pharmacogenetics of immunosuppressive drugs in organ transplantation

Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment

Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment

Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease

Aktive Filter

Suchergebnisse filtern